Scott Kim
Chief Business Officer
Zymedi
As a seasoned CBO with over 18 years in the biopharmaceutical industry, I excel in corporate business development, strategic consulting, and project management.
My expertise spans market assessment, commercial due diligence, deal valuation, strategic alliance management, corporate and R&D/BD strategy and licensing.
Skilled in global alliance management and US-focused commercialization, I have excellent track record in collaborating with key global leaders for successful outcomes.
Recognized for driving corporate growth and providing actionable insights, I have consistently contributed to the success and growth of both private and public companies in Korea and US
Speaking In
-
05-Jun-2024ZymediCompany Presentation Theater 1